TY - JOUR
T1 - Preparation of acid-responsive antibubbles from CaCO3-based Pickering emulsions.
AU - Zia, Rabia
AU - Poortinga, Albert T
AU - Nazir, Akmal
AU - Ayyash, Mutamed
AU - van Nostrum, Cornelus F
N1 - Funding Information:
This study was supported by United Arab Emirates University (Grant no. 31F143 ) and Bether Encapsulate (The Netherlands).
Publisher Copyright:
© 2023 The Authors
PY - 2023/12/15
Y1 - 2023/12/15
N2 - HYPOTHESIS: Hydrophobized fumed silica particles were previously reported for producing antibubbles that are quite stable in neutral as well as in acidic media. To produce acid-responsive antibubbles (e.g., for gastric drug delivery), the silica nanoparticles must be replaced by suitable particles, e.g., calcium carbonate (CaCO
3), which can degrade at low pH to release the encapsulated drug.
EXPERIMENTS: Two variants of CaCO
3-stabilized antibubbles were prepared (by using CaCO
3 particles pre-coated with stearic acid, or by using native CaCO
3 particles in combination with sodium stearoyl lactylate) and drug release was compared with classic antibubbles produced with hydrophobized fumed silica particles.
FINDINGS: CaCO
3 particles (pre-coated with stearic acid) can be used to produce stable antibubbles, which provided an entrapment efficiency of a model drug (methylene blue, MB) of around 85%. A burst release of MB (∼60%) from the antibubbles was observed at pH 2 (i.e., the pH of the stomach), which was further increased to 80% during the next 30 min. On the contrary, at neutral pH, about 70% of the drug remained encapsulated for at least 2 h. We further demonstrated that the acidic conditions led to the desorption of CaCO
3 particles from the air-liquid interface resulting in the destabilization of the antibubbles and the release of drug-containing cores.
AB - HYPOTHESIS: Hydrophobized fumed silica particles were previously reported for producing antibubbles that are quite stable in neutral as well as in acidic media. To produce acid-responsive antibubbles (e.g., for gastric drug delivery), the silica nanoparticles must be replaced by suitable particles, e.g., calcium carbonate (CaCO
3), which can degrade at low pH to release the encapsulated drug.
EXPERIMENTS: Two variants of CaCO
3-stabilized antibubbles were prepared (by using CaCO
3 particles pre-coated with stearic acid, or by using native CaCO
3 particles in combination with sodium stearoyl lactylate) and drug release was compared with classic antibubbles produced with hydrophobized fumed silica particles.
FINDINGS: CaCO
3 particles (pre-coated with stearic acid) can be used to produce stable antibubbles, which provided an entrapment efficiency of a model drug (methylene blue, MB) of around 85%. A burst release of MB (∼60%) from the antibubbles was observed at pH 2 (i.e., the pH of the stomach), which was further increased to 80% during the next 30 min. On the contrary, at neutral pH, about 70% of the drug remained encapsulated for at least 2 h. We further demonstrated that the acidic conditions led to the desorption of CaCO
3 particles from the air-liquid interface resulting in the destabilization of the antibubbles and the release of drug-containing cores.
KW - Acid-responsive
KW - Antibubble
KW - CaCO
KW - Drug delivery
KW - Pickering emulsion
UR - http://www.scopus.com/inward/record.url?scp=85170423000&partnerID=8YFLogxK
U2 - 10.1016/j.jcis.2023.09.007
DO - 10.1016/j.jcis.2023.09.007
M3 - Article
C2 - 37696059
SN - 0021-9797
VL - 652
SP - 2054
EP - 2065
JO - Journal of Colloid and Interface Science
JF - Journal of Colloid and Interface Science
IS - Pt B
ER -